Jones Aslynn M, Bentley Ellison, Rylander Helena
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
Current Address: Colorado State University, Fort Collins, CO 80523, USA.
Open Vet J. 2018;8(2):186-192. doi: 10.4314/ovj.v8i2.12. Epub 2018 May 26.
The cavernous sinus (CS) is a paired venous sinus that runs along either side of the pituitary gland on the floor of the calvarium. Cavernous sinus syndrome (CSS) refers to deficits in more than one of the cranial nerves III, IV, V, and VI, as they are in close association in this region. The purpose of this study was to identify the presenting complaints, neurologic findings, diagnosis, and outcomes in dogs and cats with confirmed cavernous sinus syndrome (CSS). Medical records between 2002 and 2015 were reviewed. Inclusion criteria were neurologic signs consistent with CSS and advanced imaging and/or post-mortem examination. Thirteen dogs and 2 cats were included. Twelve dogs received advanced imaging. Post-mortem examination was performed on 2 cats and 3 dogs. Dogs were 6 -13 years (mean= 10.8 years) of age and comprised of several different breeds. Both cats were male neutered domestic shorthair, ages 3 and 14 years. Presenting complaints included mydriasis (N=4), behavior changes (N=3), hyporexia (N=3), ptosis (N=2), ataxia (N=2), pain (N=2), weakness (N=2), lethargy (N=2), and one each of epiphora, ocular swelling, polydipsia, seizures, facial muscle atrophy, dysphagia, and head tilt. Neurologic signs included ophthalmoparesis/plegia (N=13), reduced/absent pupillary light response (N= 11), mydriasis (N= 10), reduced/absent corneal sensation (N= 7), ptosis (N= 6), reduced facial sensation (N= 2), and enophthalmos (N=1). Thirteen patients had a mass lesion within the cavernous sinus, 6 of which were confirmed neoplastic via histopathology. Median survival time for the 4 patients treated with radiation therapy was 1035 days (range 150-2280). Median survival for the 4 patients that received medical treatment was 360 days (range 7-1260 days), and for the 5 non-treated patients 14 days (range 0-90 days). In conclusion mydriasis and ophthalmoplegia are common signs of CSS. A mass lesion within the CS is the most common cause. Survival time may be improved with radiation therapy.
海绵窦(CS)是一对静脉窦,沿着颅腔底部垂体两侧走行。海绵窦综合征(CSS)是指由于Ⅲ、Ⅳ、Ⅴ和Ⅵ对脑神经在该区域紧密相邻,其中不止一对脑神经出现功能障碍。本研究旨在确定确诊为海绵窦综合征(CSS)的犬猫的主诉、神经学检查结果、诊断及预后情况。回顾了2002年至2015年间的病历。纳入标准为符合CSS的神经学体征以及先进的影像学检查和/或尸检。共纳入13只犬和2只猫。12只犬接受了先进的影像学检查。对2只猫和3只犬进行了尸检。犬的年龄为6 - 13岁(平均10.8岁),包括几种不同品种。两只猫均为去势的雄性家养短毛猫,年龄分别为3岁和14岁。主诉包括瞳孔散大(4例)、行为改变(3例)、食欲减退(3例)、上睑下垂(2例)、共济失调(2例)、疼痛(2例)、虚弱(2例)、嗜睡(2例),以及溢泪、眼部肿胀、多饮、癫痫发作、面部肌肉萎缩、吞咽困难和头部倾斜各1例。神经学体征包括眼球运动麻痹/瘫痪(13例)、瞳孔对光反应减弱/消失(11例)、瞳孔散大(10例)、角膜感觉减退/消失(7例)、上睑下垂(6例)、面部感觉减退(2例)和眼球内陷(1例)。13例患者在海绵窦内有占位性病变,其中6例经组织病理学确诊为肿瘤。4例接受放射治疗的患者的中位生存时间为1035天(范围150 - 2280天)。4例接受药物治疗的患者的中位生存时间为360天(范围7 - 1260天),5例未治疗的患者的中位生存时间为14天(范围0 - 90天)。总之,瞳孔散大和眼球运动麻痹是CSS的常见体征。海绵窦内的占位性病变是最常见的病因。放射治疗可能会延长生存时间。